FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166602956> ?p ?o ?g. }

• W3166602956 endingPage "425" @default.
• W3166602956 startingPage "416" @default.
• W3166602956 abstract "The therapeutic effect of multipotent mesenchymal stem cells has been proven on various disease models. One of the mechanisms is the paracrine effect of the cells on the surrounding tissues. The aim . To investigate the secretome effectiveness of the multipotent mesenchymal stem cells in the treatment of adjuvant arthritis and contact-allergic dermatitis in Wistar rats. Materials and methods. Adjuvant arthritis was simulated in 26 female rats by the administration of Freund's complete adjuvant and then treated with the administration of 100 µl of multipotent mesenchymal stem cell secretome or saline. Contact-allergic dermatitis was modeled on 30 female rats by applying 200 μl of an oil solution of dinitrofluorobenzene to the skin on days 1, 5 and 6. Then the rats were treated with fluocinolone ointment (a positive control), baby cream (a negative control), baby cream with a secretome of native multipotent mesenchymal stem cells or from the cells processed with dexamethasone. Results. Judging by the indicators of the longitudinal and transverse dimensions of the paws in rats and a histological examination, the secretome did not have any anti-inflammatory effect on adjuvant arthritis. A cream with a secret from multipotent mesenchymal stem cells processed with dexamethasone, was the most effective on the model of contact-allergic dermatitis: the clinical improvement occurred on the 2 nd day. The secretome from native multipotent mesenchymal stem cells and fluocinolone had a therapeutic effect on the 3 rd day of application, the negative control - on the 4 th day. The lymphocytic infiltration coefficient was significantly lower (p <0.05) in all the cases compared to the negative control (2.8 ± 0.1). However, the lowest infiltration was observed when the cream with secretome from native (1.75 ± 0,1) and dexamethasone-stimulated (1.76 ± 0.1) multipotent mesenchymal stem cells was being used. Conclusion. The cream with the secretome of multipotent mesenchymal stem cells suppresses lymphocytic infiltration more strongly than the highly active topical glucocorticosteroid - fluocinolone - on the model of contact-allergic dermatitis, which is a classic local delayed-type hypersensitivity reaction. However, a further study of the therapeutic effect of the secretome on models of systemic inflammatory diseases is required after its preliminary purification from large-molecular proteins." @default.
• W3166602956 created "2021-06-22" @default.
• W3166602956 creator A5017129161 @default.
• W3166602956 creator A5035778520 @default.
• W3166602956 creator A5041928995 @default.
• W3166602956 creator A5044011506 @default.
• W3166602956 creator A5048242406 @default.
• W3166602956 creator A5058524655 @default.
• W3166602956 creator A5061883850 @default.
• W3166602956 creator A5070535493 @default.
• W3166602956 creator A5075427084 @default.
• W3166602956 creator A5083705019 @default.
• W3166602956 date "2021-05-17" @default.
• W3166602956 modified "2023-09-26" @default.
• W3166602956 title "APPLICATION OF MULTIPOTENT MESENCHYMAL STEM CELL SECRETOME IN THE TREATMENT OF ADJUVANT ARTHRITIS AND CONTACT-ALLERGIC DERMATITIS IN ANIMAL MODELS" @default.
• W3166602956 cites W1523327613 @default.
• W3166602956 cites W1593070855 @default.
• W3166602956 cites W2000511007 @default.
• W3166602956 cites W2058245346 @default.
• W3166602956 cites W2122822855 @default.
• W3166602956 cites W2125508795 @default.
• W3166602956 cites W2161497340 @default.
• W3166602956 cites W2256280361 @default.
• W3166602956 cites W2340306432 @default.
• W3166602956 cites W2343997867 @default.
• W3166602956 cites W2395903840 @default.
• W3166602956 cites W2416139822 @default.
• W3166602956 cites W2508710172 @default.
• W3166602956 cites W2551140715 @default.
• W3166602956 cites W2554936801 @default.
• W3166602956 cites W2708880998 @default.
• W3166602956 cites W2772090434 @default.
• W3166602956 cites W2857550021 @default.
• W3166602956 cites W2885566869 @default.
• W3166602956 cites W2889533140 @default.
• W3166602956 cites W2892084880 @default.
• W3166602956 cites W2899794685 @default.
• W3166602956 cites W2905567844 @default.
• W3166602956 cites W2921180474 @default.
• W3166602956 cites W2943452625 @default.
• W3166602956 cites W2950379317 @default.
• W3166602956 cites W2983639930 @default.
• W3166602956 cites W2985061269 @default.
• W3166602956 cites W3024983801 @default.
• W3166602956 cites W3085136881 @default.
• W3166602956 cites W3119762858 @default.
• W3166602956 cites W3120707740 @default.
• W3166602956 cites W3166602956 @default.
• W3166602956 cites W64989981 @default.
• W3166602956 doi "https://doi.org/10.19163/2307-9266-2020-8-6-416-425" @default.
• W3166602956 hasPublicationYear "2021" @default.
• W3166602956 type Work @default.
• W3166602956 sameAs 3166602956 @default.
• W3166602956 citedByCount "2" @default.
• W3166602956 countsByYear W31666029562021 @default.
• W3166602956 countsByYear W31666029562022 @default.
• W3166602956 crossrefType "journal-article" @default.
• W3166602956 hasAuthorship W3166602956A5017129161 @default.
• W3166602956 hasAuthorship W3166602956A5035778520 @default.
• W3166602956 hasAuthorship W3166602956A5041928995 @default.
• W3166602956 hasAuthorship W3166602956A5044011506 @default.
• W3166602956 hasAuthorship W3166602956A5048242406 @default.
• W3166602956 hasAuthorship W3166602956A5058524655 @default.
• W3166602956 hasAuthorship W3166602956A5061883850 @default.
• W3166602956 hasAuthorship W3166602956A5070535493 @default.
• W3166602956 hasAuthorship W3166602956A5075427084 @default.
• W3166602956 hasAuthorship W3166602956A5083705019 @default.
• W3166602956 hasBestOaLocation W31666029561 @default.
• W3166602956 hasConcept C142724271 @default.
• W3166602956 hasConcept C198826908 @default.
• W3166602956 hasConcept C201750760 @default.
• W3166602956 hasConcept C203014093 @default.
• W3166602956 hasConcept C207480886 @default.
• W3166602956 hasConcept C2776056826 @default.
• W3166602956 hasConcept C2777077863 @default.
• W3166602956 hasConcept C2777863537 @default.
• W3166602956 hasConcept C28328180 @default.
• W3166602956 hasConcept C2910776680 @default.
• W3166602956 hasConcept C71924100 @default.
• W3166602956 hasConcept C86803240 @default.
• W3166602956 hasConcept C95444343 @default.
• W3166602956 hasConceptScore W3166602956C142724271 @default.
• W3166602956 hasConceptScore W3166602956C198826908 @default.
• W3166602956 hasConceptScore W3166602956C201750760 @default.
• W3166602956 hasConceptScore W3166602956C203014093 @default.
• W3166602956 hasConceptScore W3166602956C207480886 @default.
• W3166602956 hasConceptScore W3166602956C2776056826 @default.
• W3166602956 hasConceptScore W3166602956C2777077863 @default.
• W3166602956 hasConceptScore W3166602956C2777863537 @default.
• W3166602956 hasConceptScore W3166602956C28328180 @default.
• W3166602956 hasConceptScore W3166602956C2910776680 @default.
• W3166602956 hasConceptScore W3166602956C71924100 @default.
• W3166602956 hasConceptScore W3166602956C86803240 @default.
• W3166602956 hasConceptScore W3166602956C95444343 @default.
• W3166602956 hasIssue "6" @default.
• W3166602956 hasLocation W31666029561 @default.
• W3166602956 hasOpenAccess W3166602956 @default.
• W3166602956 hasPrimaryLocation W31666029561 @default.

• next